-
Bordeaux-Begles handed favourable draw in Champions Cup defence
-
Key challenges for Laporta in second Barca term
-
'Thought they'd never be caught': The strike that killed Iran's Khamenei
-
Canada to join Eurovision Song Contest
-
Djokovic, Sinner hope for easier ride after Wimbledon scares
-
Swedish court orders Google pay $1.46 bn for favouring its price comparisons
-
Injured Serena's Wimbledon doubles bid with sister Venus in doubt
-
German FA headquarters searched in Euro 2024 graft probe
-
European stocks mostly drop with eyes on US Fed
-
Village People singer Victor Willis dies at 74
-
Genesio replaces Beye as Marseille boss
-
Thousands rush to get tickets for Bayeux Tapestry's UK show
-
Catholic society defies Vatican again by ordaining new bishops
-
Chinese firm sells hyper-real, 'always loyal' humanoid robots
-
Breakaway Catholic society defies Vatican again by ordaining bishops
-
World's oceans break June heat record: EU monitor
-
Venezuelans search, suffer one week after deadly quakes
-
China imposes 'national security' rules on overseas investments
-
Asian stocks mostly up as traders eye crucial US jobs data
-
'Nothing left except death': Myanmar families grieve huge war toll
-
Ronaldo and Modric struggle to defy Father Time at World Cup
-
England face DR Congo hurdle, USA prepare for World Cup moment in spotlight
-
The secret lives of Ukraine's deep-strike drone team
-
Myanmar mourns as post-coup conflict death toll hits 100,000
-
NATO project tests perennial grass to clean Ukraine's war-hit soil
-
Vietnam unveils 'baby bonus' after scrapping two-child policy
-
Duffy returns for New Zealand against West Indies
-
Majestic Olise raises France to another level at World Cup
-
Mbappe dazzles as France march on at World Cup; Norway, Mexico advance
-
Mexico see off Ecuador to break 40-year World Cup curse
-
US govt lifts restrictions on powerful AI models, Anthropic says
-
'My dream is broken': Japan visa rules push out foreign residents
-
Trump earned over $1 bn from crypto ventures in 2025
-
Indian sailors fear returning to Gulf after Middle East war
-
The Afghan women farmers keeping their village alive
-
Fear and anger brew inside Meta amid AI frenzy
-
Asian stocks fluctuate as traders eye crucial US jobs data
-
After 250 years, the 'American dream' is tarnished but alive
-
Madison Square Garden: from Nazis to Knicks, and now... Taylor's wedding?
-
'I'm going to stay calm': 48 hours under the rubble in Venezuela
-
'Love it': Wimbledon's military stewards tradition turns 80
-
Breakaway Catholic sect defies Vatican again by ordaining bishops
-
Venezuela quake survivors cherish kindness of strangers
-
Mexico v Ecuador World Cup game delayed by one hour: FIFA
-
US deports first migrant to Pacific nation Palau
-
Talks in Qatar after US-Iran deal: What we know
-
Potter admits Sweden couldn't live with France in World Cup defeat
-
Tuchel refuses to dampen England World Cup expectations
-
US coach dismisses European jinx ahead of Bosnia clash
-
Mbappe hails unity as France rally around Deschamps at World Cup
WHO triggers highest alert on monkeypox
The World Health Organization on Saturday declared the monkeypox outbreak, which has affected nearly 16,000 people in 72 countries, to be a global health emergency -- the highest alarm it can sound.
"I have decided that the global #monkeypox outbreak represents a public health emergency of international concern," WHO chief Tedros Adhanom Ghebreyesus said at a press conference.
He said a committee of experts who met on Thursday was unable to reach a consensus, so it fell on him to decide whether to trigger the highest alert possible.
"WHO's assessment is that the risk of monkeypox is moderate globally and in all regions, except in the European region where we assess the risk as high," he added.
Monkeypox has affected over 15,800 people in 72 countries, according to a tally by the US Centers for Disease Control and Prevention (CDC) published on July 20.
A surge in monkeypox infections has been reported since early May outside the West and Central African countries where the disease has long been endemic.
On June 23, the WHO convened an emergency committee (EC) of experts to decide if monkeypox constitutes a so-called Public Health Emergency of International Concern (PHEIC) -- the UN health agency's highest alert level.
But a majority advised Tedros that the situation, at that point, had not met the threshold.
The second meeting was called on Thursday with case numbers rising further, where Tedros said he was worried.
"I need your advice in assessing the immediate and mid-term public health implications," Tedros told the meeting, which lasted more than six hours.
A US health expert sounded a grim warning late on Friday.
"Since the last #monkeypox EC just weeks ago, we've seen an exponential rise in cases. It's inevitable that cases will dramatically rise in the coming weeks & months. That's why @DrTedros must sound the global alarm," Lawrence Gostin, the director of the WHO Collaborating Center on National and Global Health Law, said on Twitter.
"A failure to act will have grave consequences for global health."
- Warning against discrimination -
A viral infection resembling smallpox and first detected in humans in 1970, monkeypox is less dangerous and contagious than smallpox, which was eradicated in 1980.
Ninety-five percent of cases have been transmitted through sexual activity, according to a study of 528 people in 16 countries published in the New England Journal of Medicine -- the largest research to date.
Overall, 98 percent of infected people were gay or bisexual men, and around a third were known to have visited sex-on-site venues such as sex parties or saunas within the previous month.
"This transmission pattern represents both an opportunity to implement targeted public health interventions, and a challenge because in some countries, the communities affected face life-threatening discrimination," Tedros said earlier, citing concern that stigma and scapegoating could make the outbreak harder to track.
The European Union's drug watchdog on Friday recommended for approval the use of Imvanex, a smallpox vaccine, to treat monkeypox.
Imvanex, developed by Danish drugmaker Bavarian Nordic, has been approved in the EU since 2013 for the prevention of smallpox.
It was also considered a potential vaccine for monkeypox because of the similarity between the monkeypox virus and the smallpox virus.
The first symptoms of monkeypox are fever, headaches, muscle pain and back pain during the course of five days.
Rashes subsequently appear on the face, the palms of hands and soles of feet, followed by lesions, spots and finally scabs.
J.Horn--BTB